{"pmid":32283237,"title":"Hydroxychloroquine and ivermectin: a synergistic combination for COVID-19 chemoprophylaxis and/or treatment?","text":["Hydroxychloroquine and ivermectin: a synergistic combination for COVID-19 chemoprophylaxis and/or treatment?","J Am Acad Dermatol","Patri, Angela","Fabbrocini, Gabriella","32283237"],"journal":"J Am Acad Dermatol","authors":["Patri, Angela","Fabbrocini, Gabriella"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32283237","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jaad.2020.04.017","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663989232659595264,"score":7.979339,"similar":[{"pmid":32251768,"title":"The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro.","text":["The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro.","Although several clinical trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited to monitoring/containment. We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addition to Vero-hSLAM cells 2 hours post infection with SARS-CoV-2 able to effect approximately 5000-fold reduction in viral RNA at 48 h. Ivermectin therefore warrants further investigation for possible benefits in humans.","Antiviral Res","Caly, Leon","Druce, Julian D","Catton, Mike G","Jans, David A","Wagstaff, Kylie M","32251768"],"abstract":["Although several clinical trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited to monitoring/containment. We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addition to Vero-hSLAM cells 2 hours post infection with SARS-CoV-2 able to effect approximately 5000-fold reduction in viral RNA at 48 h. Ivermectin therefore warrants further investigation for possible benefits in humans."],"journal":"Antiviral Res","authors":["Caly, Leon","Druce, Julian D","Catton, Mike G","Jans, David A","Wagstaff, Kylie M"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32251768","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.antiviral.2020.104787","source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"_version_":1663352136233123840,"score":54.554577},{"pmid":32240719,"title":"No Evidence of Rapid Antiviral Clearance or Clinical Benefit with the Combination of Hydroxychloroquine and Azithromycin in Patients with Severe COVID-19 Infection.","text":["No Evidence of Rapid Antiviral Clearance or Clinical Benefit with the Combination of Hydroxychloroquine and Azithromycin in Patients with Severe COVID-19 Infection.","Med Mal Infect","Molina, Jean Michel","Delaugerre, Constance","Goff, Jerome Le","Mela-Lima, Breno","Ponscarme, Diane","Goldwirt, Lauriane","de Castro, Nathalie","32240719"],"journal":"Med Mal Infect","authors":["Molina, Jean Michel","Delaugerre, Constance","Goff, Jerome Le","Mela-Lima, Breno","Ponscarme, Diane","Goldwirt, Lauriane","de Castro, Nathalie"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32240719","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.medmal.2020.03.006","source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Hydroxychloroquine","Azithromycin"],"_version_":1663352135441448960,"score":48.65539},{"pmid":32113509,"title":"COVID-19: combining antiviral and anti-inflammatory treatments.","text":["COVID-19: combining antiviral and anti-inflammatory treatments.","Lancet Infect Dis","Stebbing, Justin","Phelan, Anne","Griffin, Ivan","Tucker, Catherine","Oechsle, Olly","Smith, Dan","Richardson, Peter","32113509"],"journal":"Lancet Infect Dis","authors":["Stebbing, Justin","Phelan, Anne","Griffin, Ivan","Tucker, Catherine","Oechsle, Olly","Smith, Dan","Richardson, Peter"],"date":"2020-03-02T11:00:00Z","year":2020,"_id":"32113509","week":"202010|Mar 02 - Mar 08","doi":"10.1016/S1473-3099(20)30132-8","link_comment_for":"32032529","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663352134361415681,"score":47.907597}]}